Lack of effect of coumarin on unscheduled DNA synthesis in the in vivo rat hepatocyte DNA repair assay

Food and Chemical Toxicology

Volumn 38, Issue 5, 2000, Pages 403-409

  Edwards, A J ^a   Price, R J ^a   Renwick, A B ^a   Lake, B G ^a  

^a TNO BIBRA International Ltd   (United Kingdom)

Author keywords

Coumarin; In vivo DNA repair; Rat hepatocytes; Unscheduled DNA synthesis

Indexed keywords

COUMARIN; DIMETHYLNITROSAMINE; N (2 FLUORENYL)ACETAMIDE;

ANIMAL CELL; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA REPAIR; LIVER CELL; LIVER TOXICITY; MALE; NONHUMAN; RAT; SISTER CHROMATID EXCHANGE; UNSCHEDULED DNA SYNTHESIS;

2-ACETYLAMINOFLUORENE; ANIMALS; ANTICOAGULANTS; CELL SEPARATION; CELLS, CULTURED; COUMARINS; DIMETHYLNITROSAMINE; DNA; DNA REPAIR; DNA REPLICATION; LIVER; MALE; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; ZEA MAYS;

EID: 0034029214     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(00)00016-8     Document Type: Article

References (44)

1. Beamand J. A., Barton P. T., Price R. J., Lake B. G. Lack of effect of coumarin on unscheduled DNA synthesis in precision-cut human liver slices. Food and Chemical Toxicology. 36:1998;647-653.
2. Born S. L., Hu J. K., Lehman-McKeeman L. D. o-Hydroxyphenylacetaldehyde (o-HPA) is a hepatotoxic metabolite of coumarin. Toxicological Sciences. 42:(No. 1-S):1998;400.
3. Born S. L., Rodriguez P. A., Eddy C. L., Lehman-McKeeman L. D. Synthesis and reactivity of coumarin 3,4-epoxide. Drug Metabolism and Disposition. 25:1997;1318-1323.
4. Butterworth B. E., Ashby J., Bermudez E., Casciano D., Mirsalis J., Probst G., Williams G. A protocol and guide for the in vivo rat hepatocyte DNA-repair assay. Mutation Research. 189:1987;123-133.
5. Butterworth B. E., Bermudez E., Smith-Oliver T., Earle L., Cattley R., Martin J., Popp J. A., Strom S., Jirtle R., Michalopoulos G. Lack of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytes. Carcinogenesis. 5:1984;1329-1335.
6. Carlton B. D., Aubrun J-C., Simon G. S. Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and CD-1 mice. Fundamental and Applied Toxicology. 30:1996;145-151.
7. Cattley R. C., Richardson K. K., Smith-Oliver T., Popp J. A., Butterworth B. E. Effect of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat hepatocytes determined by autoradiography. Cancer Letters. 33:1986;269-277.
8. Cohen A. J. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food and Chemical Toxicology. 17:1979;277-289.
9. Evans J. G., Appleby E. C., Lake B. G., Conning D. M. Studies on the induction of cholangiofibrosis by coumarin in the rat. Toxicology. 55:1989;207-224.
10. Fentem J. H., Fry J. R., Whiting D. A. o-Hydroxyphenylacetaldehyde : a major novel metabolite of coumarin formed by rat, gerbil and human liver microsomes. Biochemical and Biophysical Research Communications. 179:1991;197-203.
11. Fernandez-Salguero P., Hoffman S. M. G., Cholerton S., Mohrenweiser H., Raunio H., Rautio A., Pelkonen O., Huang J-D., Evans W. E., Idle J. R., Gonzalez F. J. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. American Journal of Human Genetics. 57:1995;650-651.
12. Galloway S. M., Armstrong M. J., Reuben C., Colman S., Brown B., Cannon C., Bloom A. D., Nakamura F., Ahmed M., Duk S., Rimpo J., Margolin B. H., Resnick M. A., Anderson B., Zeiger E. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environmental and Molecular Mutagenesis. 10:(Suppl. 10):1987;1-175.
13. Gangolli S. D., Shilling W. H., Grasso P., Gaunt I. F. Studies on the metabolism and hepatotoxicity of coumarin in the baboon. Biochemical Society Transactions. 2:1974;310-312.
14. Gray T. J. B., Lake B. G., Beamand J. A., Foster J. R., Gangolli S. D. Peroxisome proliferation in primary cultures of rat hepatocytes. Toxicology and Applied Pharmacology. 67:1983;15-25.
15. Gullstén H., Agúndez J. A. G., Benítez J., Läärä E., Ladero J. M., Díaz-Rubio M., Fernandez-Salguero P., Gonzalez F., Rautio A., Pelkonen O., Raunio H. CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis. Pharmacogenetics. 7:1997;247-250.
16. Hadidi H., Zahlsen K., Idle J. R., Cholerton S. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food and Chemical Toxicology. 35:1997;903-907.
17. Hagan E. C., Hansen W. H., Fitzhugh O. G., Jenner P. M., Jones W. I., Taylor J. M., Long E. L., Nelson A. A., Brouwer J. B. Food flavourings and compounds of related structure. II. Subacute and chronic toxicity. Food and Cosmetics Toxicology. 5:1967;141-157.
18. Haworth S., Lawlor T., Mortelmans K., Speck W., Zeiger E. Salmonella mutagenicity test results for 250 chemicals. Environmental Mutagenesis. 5:(Suppl. 1):1983;3-142.
19. 14C]coumarin. Journal of Medicinal Chemistry. 3:1961;25-43.
20. Kennelly J. C. Design and interpretation of rat liver UDS assays. Mutagenesis. 10:1995;215-221.
21. Kennelly J. C., Waters R., Ashby J., Lefevre P. A., Burlinson B., Benford D. J., Dean S. W. and Mitchell de I. G. (1993) In vivo rat liver UDS assay. In Supplementary Mutagenicity Tests: UKEMS Recommended Procedures, ed. D. J. Kirkland and M. Fox, pp. 52-77. Cambridge University Press, Cambridge.
22. Lake B. G. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food and Chemical Toxicology. 37:1999;423-453.
23. Lake B. G., Grasso P. Comparison of the hepatotoxicity of coumarin in the rat, mouse and Syrian hamster: a dose and time response study. Fundamental and Applied Toxicology. 34:1996;105-117.
24. 14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans. Food and Chemical Toxicology. 30:1992;105-115.
25. Lake B. G., Evans J. G., Lewis D. F. V., Price R. J. Studies on the acute effects of coumarin and some coumarin derivatives in the rat. Food and Chemical Toxicology. 32:1994;357-363.
26. Lake B. G., Evans J. G., Walters D. G., Price R. J. Studies on the hepatotoxicity and metabolism of coumarin in the rat and Syrian hamster. Human and Experimental Toxicology. 9:1990;356.
27. Lake B. G., Gray T. J. B., Evans J. G., Lewis D. F. V., Beamand J. A., Hue K. L. Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites. Toxicology and Applied Pharmacology. 97:1989;311-323.
28. Lake B. G., Osborne D. J., Walters D. G., Price R. J. Identification of o-hydroxyphenylacetaldehyde as a major metabolite of coumarin in rat hepatic microsomes. Food and Chemical Toxicology. 30:1992;99-104.
29. Lovell D. P., van Iersel M., Walters D. G., Price R. J., Lake B. G. Genetic variation in the metabolism of coumarin in mouse liver. Pharmacogenetics. 9:1999;239-250.
30. Loury D. J., Smith-Oliver T., Strom S., Jirtle R., Michalopoulos G., Butterworth B. E. Assessment of unscheduled and replicative DNA synthesis in hepatocytes treated with unleaded gasoline or 2,2,4-trimethylpentane. Toxicology and Applied Pharmacology. 85:1986;11-23.
31. Lush I. E., Andrews K. M. Genetic variation between mice in their metabolism of coumarin and its derivatives. Genetics Research. 31:1978;177-186.
32. Mackay J. M., Elliott B. M. Dose-ranging and dose-setting for in vivo genetic toxicology studies. Mutation Research. 271:1992;97-99.
33. Madle S., Dean S. W., Andrae U., Brambilla G., Burlinson B., Doolittle D. J., Furihata C., Hertner T., McQueen C. A., Mori H. Recommendations for the performance of UDS tests in vitro and in vivo. Mutation Research. 312:1994;263-285.
34. Morris D. L., Ward J. B. Jr. Coumarin inhibits micronuclei formation induced by benzo(a)pyrene in male but not female ICR mice. Environmental and Molecular Mutagenesis. 19:1992;132-138.
35. 1 mice (gavage studies). National Toxicology Program. Technical Report No. NTP TR 422. NIH Publication No. 93-3153. US Department of Health and Human Services, NIH, Research Triangle Park, NC.
36. Opdyke D. L. J. Monographs on fragrance raw materials: coumarin. Food and Chemical Toxicology. 12:1974;385-388.
37. Sasaki Y. F., Imanishi H., Ohta T., Shirasu Y. Effects of antimutagenic flavourings on SCEs induced by chemical mutagens in cultured Chinese hamster cells. Mutation Research. 189:1987;313-318.
38. Sasaki Y. F., Imanishi H., Watanabe M., Ohta T., Shirasu Y. Suppressing effect of antimutagenic flavorings on chromosome aberrations induced by UV-light or X-rays in cultured Chinese hamster cells. Mutation Research. 229:1990;1-10.
39. Shilling W. H., Crampton R. F., Longland R. C. Metabolism of coumarin in man. Nature. 221:1969;664-665.
40. Soine T. O. Naturally occurring coumarins and related physiological activities. Journal of Pharmaceutical Sciences. 53:1964;231-264.
41. Ueno I., Hirono I. Non-carcinogenic response to coumarin in Syrian golden hamsters. Food and Chemical Toxicology. 19:1981;353-355.
42. Valencia R., Mason J. M., Zimmering S. Chemical mutagenesis testing in Drosophila. VI. Interlaboratory comparison of mutagenicity tests after treatment of larvae. Environmental and Molecular Mutagenesis. 14:1989;238-244.
43. Williams G. M. Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Research. 37:1977;1845-1851.
44. Yoon J. S., Mason J. M., Valencia R., Woodruff R. C., Zimmering S. Chemical mutagenesis testing in Drosophila. IV. Results of 45 coded compounds tested for the National Toxicology Program. Environmental Mutagenesis. 7:1985;349-367.